Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
23 Leser
Artikel bewerten:
(0)

AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year

NORTH CHICAGO, Illinois, Oct. 23, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that Science/Science Careers has included AbbVie in its annual Top Employers Survey, as surveyed by more than 5,000 respondents in the biotechnology, pharmaceutical and biopharmaceutical industries.

"It is an honor to once again be named among the top employers in Science magazine's annual ranking in our second year as an independent company," said Michael Severino, M.D., executive vice president, Research and Development and chief scientific officer, AbbVie. "Each of our employees brings their own innovative ideas, approaches and experience to AbbVie. This important recognition underscores that we are creating the right culture and shared commitments to great science, to R&D, and to improving patient care around the world."

The 2014 ranking of companies with the best reputations as employers was based on 5,394 survey responses from readers of Science and other survey invitees. Respondents to the survey were asked to rate companies based on 23 characteristics such as financial strength, easy adaptation to change, and a research-driven environment. Ninety-one percent of survey participants work in biotechnology, pharmaceutical and pharmaceutical companies and are from North America (70 percent), Europe (23 percent), and Asia/Pacific Rim (6 percent).

The complete feature along with individual company rankings can be found online or in the October 17, 2014 print edition of Science.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visitwww.abbvie.com. Follow@abbvieon Twitter or view careers on ourFacebookorLinkedInpage.

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.